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Abstract
Background: The new REACH legislation requires assessment of a large number of chemicals in the European
market for several endpoints. Developmental toxicity is one of the most difficult endpoints to assess, on account of
the complexity, length and costs of experiments. Following the encouragement of QSAR (in silico) methods
provided in the REACH itself, the CAESAR project has developed several models.
Results: Two QSAR models for developmental toxicity have been developed, using different statistical/
mathematical methods. Both models performed well. The first makes a classification based on a random forest
algorithm, while the second is based on an adaptive fuzzy partition algorithm. The first model has been
implemented and inserted into the CAESAR on-line application, which is java-based software that allows everyone
to freely use the models.
Conclusions: The CAESAR QSAR models have been developed with the aim to minimize false negatives in order
to make them more usable for REACH. The CAESAR on-line application ensures that both industry and regulators
can easily access and use the developmental toxicity model (as well as the models for the other four endpoints).
Background
Developmental toxicity is receiving increasing attention
on account of its adverse impact at the level of the spe-
cies [1]. Developmental toxicity refers to any effect
interfering with normal development, both before and
after birth. This includes embryotoxic/foetotoxic effects
such as reduced body weight, growth and developmental
retardation, organ toxicity, death, abortion, structural
defects (teratogenic effects), functional effects, peri- and
postnatal defects, and impaired postnatal mental or phy-
sical development up to normal pubertal development.
This important endpoint is more problematic to assess
than other endpoints [2]. Developmental toxicity
involves several aspects and a series of experimental
methods can be adopted. The complexity, length, and
cost of the experiments, and the late recognition of the
importance of this endpoint have resulted in a low num-
ber of available studies.
The European legislation REACH requires specific
assessment of developmental toxicity [3]. As part of the
CAESAR project [4] we addressed developmental toxi-
city, in collaboration with the US Environmental Protec-
tion Agency, using quantitative structure-activity
relationship (QSAR) models. QSAR models are welcome
in REACH, which recognizes that new tools are needed
to cope with the huge task of assessing the vast number
of chemicals in the European market. Animal studies,
which are at the basis of QSAR models for toxicity, can-
not alone guarantee the production of all necessary
data. Limits of traditional experimental methods include
the costs and time they need, ethical concern about use
of animals, and the relatively small number of labora-
tories that can do the experiments. Furthermore, current
experimental methods are not universal and cannot pro-
vide suitable evaluations for certain properties. Innova-
tion is therefore a major aim of REACH, as stated in its
first article [3].
CAESAR wants to contribute to this effort to intro-
duce new methods, which are useful in the case of
developmental toxicity. Thus besides developing the
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paper describes models for developmental toxicity
obtained within CAESAR and describes the web-based
platform, which contains the system for obtaining pre-
dictions automatically using the simple chemical
structure.
Results
The CAESAR models
The CAESAR project’s primary goal was to develop
QSAR models and make them easily accessible and
usable by anyone (regulators, manufacturers, etc). The
first part of this section describes QSAR models for
developmental toxicity, and the second part discusses
the platform developed to make the models accessible.
Information on development toxicity is important for
a general evaluation of the toxicity of chemicals. Devel-
opmental toxicity is a complex endpoint, and there is
very little information. Our models, like other models
for this endpoint, are based on available data. The qual-
ity of any model depends on the quality of the data
u s e da si n p u t .T h ed a t aw eu s e dw a st a k e nf r o mA r e n a
et al. [5], which is a collection of good quality data and
was the largest we found when the project started.
Moreover, it includes a heterogeneous list of chemicals,
belonging to different chemical classes. The quality of
this data set has been checked by the CAESAR consor-
tium, for both the property classes and chemical struc-
tures (see experimental part). The collection starts from
experimental values on animal toxicity, and human stu-
dies or case reports [6,7] on potentially teratogenic che-
micals, so on this basis the possible human toxicity
effect was evaluated. The original toxicity classes were
further checked within the CAESAR project, as detailed
in the experimental section. The modeling tool is a bin-
ary classifier, and thus the model predicts whether the
chemical is toxic or not.
The validation of a QSAR model is important if a par-
ticular QSAR model is to be used for predictive pur-
poses [8,9]. In the past most QSAR models only
reported the statistical characteristics of fitting. In order
to assess the models’ predictive performance we devel-
oped the models using only 80% of the chemicals avail-
able as training set, and the other 20% for external
validation as a test set. Regulators often prefers the use
of an external test set because it can immediately show
whether the model is predictive towards new chemicals
[8,9]. In practice, the availability of experimental data is
a major issue in many cases. In our case the chosen
solution, 20% as test set was suitable considering the
number of available compounds. Matthews et al. studied
developmental toxicity models using 10% of the com-
pounds to form the validation set, starting from more
than 900 compounds [10]. Arena et al. did not use an
external test set [5]. Besides external validation, we also
used the leave-several-out method for internal valida-
tion. It is well recognized the validation of a QSAR
model is important in case a particular QSAR model
will be used for predictive purposes.
Within CAESAR we developed tens of predictive
models for this endpoint. Here we report the results for
the two models that gave the best results: a random for-
est (RF) model (based on 13 descriptors) and an adap-
tive fuzzy partition (AFP) model (based on 6
descriptors). The prediction statistics for the RF and
AFP models are given in Tables 1 and 2, respectively.
The definitions of the prediction statistics in Tables 1
and 2 are given in Table 3.
The RF model shows good accuracy in the test set
(84%), and in fitting (100%), with few false negatives
(95% sensitivity). The AFP model shows high accuracy
in the test set (88%) and in fitting (87%) with a good
balance between sensitivity (90%) and specificity (82%).
The results shown in Table 2 with the AFP model were
obtained after removing one compound (etoposide),
because the AFP model could not predict it. Indeed, the
descriptor values for etoposide are outside the domain
applicability of the AFP model for one descriptor. The
quality of the models also appears good with internal
validation: the accuracy in cross-validation (leave-sev-
eral-out) was 77% for the RF model, and 72% for the
AFP. We used ten-fold cross-validation for RF, and
leave-one-out for AFP. These results are better than
those previously published on the same dataset [5,11].
These studies applied two different methods: CART
decision tree and logistic regression. The prediction sta-
tistics for CART were as follows: accuracy 57-63%; sen-
sitivity 58-64%; specificity 57-66%. The statistics for
logistic regression were similar: accuracy 60-62%; sensi-
tivity 60-63%; specificity 59-62%.
Other studies on developmental toxicity have modeled
individual animal endpoints [10,12]. Accuracy in these
cases ranged from 45 to 88% for reproductive toxicity,
and sensitivity from 10 to 72% (however, for the last
Table 1 Validation statistics from the RF model for
developmental toxicity
Statistical parameters* Fitting on the
training set
Prediction on the
test set
Accuracy 100% 84%
FP% 0% 41%
FN% 0% 5%
PPV 100% 85%
NPV 100% 83%
Sensitivity 100% 95%
Specificity 100% 59%
* The definition of these parameters is in Table 3.
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the results from the CAESAR models are good com-
pared to those in the literature.
Thus, the CAESAR models offer an improvement over
previous models based on the same set of compounds,
and perform well compared with other studies on devel-
opmental toxicity. Our set of compounds includes a het-
erogeneous list of chemicals, from different classes. The
same applies to the other models on developmental
toxicity mentioned above.
However, the quality of a model itself is not sufficient
for use. In most cases models presented in the literature
are not used at all, because the possibility of applying
them is typically limited by several obstacles. The user
must proceed through a long series of steps, using pro-
grams which are often hard to find and reproduce. Typi-
cally, to apply a QSAR model the user has to calculate
chemical descriptors, then apply the model algorithm to
get the result [13]. However, several facts may put
obstacles in this path limiting reproducibility. Some
parts of the algorithm may be private and not distribu-
ted. Then, different programs to calculate chemical
descriptors handle chemical structures in different ways.
Thus, even apparently simple descriptors such as the
number of double bonds, may provide different values
when calculated with different programs or even
different versions of the same software. Even worse is
the situation with tri-dimensional descriptors, because
in most cases they involve manual optimization or sto-
chastic processes.
For developmental toxicity we developed tens of mod-
els. Since tri-dimensional descriptors are typically more
difficult to calculate and in our case did not yield better
results, the final CAESAR models included only
bi-dimensional descriptors.
As part of the CAESAR project we organized a work-
shop (Milan, 10-11 March, 2009) [4] to discuss the
results with regulatory stakeholders and industry repre-
sentatives. Participants (about 130) included regulatory
representatives from nearly all 25 European Union
members and associated countries, and many from
industry. We asked which features were most desirable
for QSAR models and how to make the models more
usable. This discussion led to a platform to make the
CAESAR models available and some modules were
added following users’ recommendations.
This led to the development of a free web-based appli-
cation that allows one to submit a list of compounds,
execute the QSAR model of interest, and obtain results
easily. So far, the developmental toxicity model devel-
oped with the RF algorithm has been implemented in
the application, together with other models for the four
other end-points selected for the CAESAR project.
The CAESAR application has a client-server architec-
ture. The user accesses the application from his/her web
browser, and can use the latest models available on the
central server. More details are given in Additional file 1.
The model has one particularly valuable feature: the
results are intrinsically-reproducible. Starting from a
certain structure only one value can be obtained by all
users.
The CAESAR model platform
All CAESAR models are implemented with a similar
user interface, designed to be simple and user-friendly.
Table 2 Validation statistics from the AFP model for
developmental toxicity
Statistical parameters* Fitting on the
training set
Prediction on the
test set
Accuracy 87% 88%
FP% 26% 18%
FN% 7% 10%
PPV 89% 92%
NPV 83% 78%
Sensitivity 93% 90%
Specifificy 74% 82%
* The definition of these parameters is in Table 3.
Table 3 Statistical variables of the performance of a binary classification test
Acronym Full name Definition/Formula
TP True positive Toxic compounds predicted as toxic
TN True negative Non toxic compounds predicted as non toxic
FP False positive Non toxic compounds predicted as toxic
FN False negative Toxic compounds predicted as non toxic
FP% False positive rate Ratio of non toxic compounds incorrectly classified as toxic FP/(FP + TN)
FN% False negative rate Ratio of toxic compounds incorrectly classified as non toxic FN/(FN + TP)
Sensitivity Sensitivity or true positive rate Ratio of toxic compounds correctly classified as toxic TP/(TP + FN)
Specificity Specificity or true negative rate Ratio of non toxic compounds correctly classified as non toxic TN/(FP + TN)
Accuracy Accuracy or concordance Proportion of the total number of predictions that were correct (TP + TN)/(TP + TN + FP + FN)
PPV Positive predictive value Ratio of the predicted toxic compounds that were correct TP/(TP + FP)
NPV Negative predictive value Ratio of the predicted non toxic compounds that were correct TN/(TN + FN)
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all the necessary descriptors are calculated directly on
the server side. The user follows three steps to execute
the model.
In the first step the user loads the desired data; this
can be done either by uploading a recognized molecular
file (.SDF or .SMI) or by entering the structures of the
compounds of interest using the simplified molecular
input line entry system (SMILES) strings [14]. All the
molecules are then listed in a grid, and when a desired
element of the grid is highlighted, the bi-dimensional
structure of the compound is shown.
In the second step, all molecules are sent to the CAE-
SAR server for the calculation of the model. When the
remote execution is terminated, the user can see the set
of compounds and predictions resulting from the model
in the grid. When a compound is highlighted, details
about its prediction are reported, and it is possible to
check the six most similar compounds found in the
model database (see below for further details).
The final step lets the user save the prediction made
by the model in two possible formats, plain text or por-
table document format - PDF. The first format reports
the predictions in a tab delimited text file which can be
imported into other software (such as a spreadsheet).
The second format is a full report in PDF format, which
reports the compound, its depiction, and the six most
similar compounds in the database along with their bi-
dimensional structures.
We presented the CAESAR platform in a few courses
and at the CAESAR workshop. The CAESAR platform
was well accepted by users from different backgrounds.
All said they found it clearer and easier than other freely
available tools for human toxicity. A clearer platform
makes errors less likely. Furthermore, the user has no
options to choose from and this makes the results with
CAESAR reproducible.
Applicability domain
An important issue for the proper interpretation of the
results of a QSAR model is the applicability domain
(AD), i.e. an evaluation of how suitable the model is for
reliable prediction for the given compounds. Evaluation
of the AD is required by REACH.
Within the CAESAR platform, the user can evaluate
t h eA Du s i n gt h r e ea p p r o a c h e s .T h ef i r s tr e f e r st oc h e -
mical descriptors or fragments related to the whole data
set; the second is a similarity tool to show the six com-
pounds of the training set most similar to the submitted
chemical; the third allows an evaluation of the goodness
or errors in prediction for these six compounds.
The first tool explores the whole set of compounds in
the training set, and includes a remark if problems
appear in relation to the overall set of descriptors or
fragments. Each CAESAR model has its own method for
this assessment, depending on the type of model (for
example, checking the range of molecular descriptors, or
application of expert-based rules, etc.). This assessment
is reported with the results for the model, where each
compound has a field headed “remarks”. If problems are
found concerning the AD, the user is warned that the
prediction may not be reliable as the molecule falls out-
side the model’s AD. In the case of the model for devel-
opmental toxicity, the platform verifies whether the
descriptors of the new compounds are inside the range
of the descriptors used for the training set.
B e s i d e st h i st o o lf o rA D( w h i c hi sb a s e do nt h ec h e -
mometric approach and thus on the input space, i.e.the
chemical descriptors and fragments), there is a second
tool in the CAESAR platform that enables the user to
visualize the six molecules from the model’s training set
which are the most similar to a given compound.
Furthermore, a similarity score tool has been
implemented.
The question of formal measurement of the “similar-
ity” between compounds is complex and has no clear
solution. Several approaches have been proposed and
used [15]. In the CAESAR application, we implemented
an integrated index using both count descriptors and
fingerprints, taking account of different aspects of che-
mical similarity in order to obtain a broad measurement
of similarity. The index is based on four sub-indices,
explained below:
￿ Functional Group Similarity (FGs): built as the
sequence of all values of the Functional Group mole-
cular descriptors as calculated by DRAGON [16],
where each descriptor reports the number of occur-
rences of a particular functional group.
￿ Constitutional Similarity (Cs): built as the sequence
of some molecular descriptors calculated by DRA-
GON in the Constitutional block: nH, nC, nN, nO,
nP, nS, nF, nCL, nBR, nI, nB, nHM, nX; each
descriptor reports the number of some kind of atom.
￿ Ring Similarity (Rs): built as the sequence of some
molecular descriptors calculated by DRAGON in the
Constitutional block: nCIC, nCIR, nR03, nR04,
nR05, nR06, nR07, nR08, nR09, nR10, nR11, nR12,
nBnz; each descriptor reports the count of each ring
size.
￿ Fingerprint Similarity (FPs): built as a standard fin-
gerprint as defined in the Daylight theory [17], with
1024 characters and deep 7. Thus it takes into
account all the possible fragments of the molecule
made of up to 7 elements.
These four sub-indices are used to calculate a similar-
ity index based on the Tanimoto coefficient [18], so that
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final similarity index is calculated using a utility function
between these four, assigning a weight for each:
S 3 FGs 2 Cs 2 Rs 3 FPs = () + () + () + () 00 0 0 .* .* .* .*
The index S is still in the interval (0,1), as required by
our similarity index. The weights were chosen to ensure
good distribution of the values in the interval (0,1).
When the compound of interest is present in the train-
ing set 1 is obtained. In some cases 0 can be obtained
for chemicals which are very different from those in the
training set. If the model data set does not have a mole-
cule similar to the one submitted, the confidence in the
predicted value decreases. Since the six most similar
chemicals are shown, besides the similarity score users
can apply their own experience to evaluate similarity.
This feature has also been added on the basis of
requests from the workshop.
As a further tool, users can check the difference
between the experimental and predicted values for these
six similar compounds. This feature allows one to evalu-
ate the model’s validity for the specific domain in the
vicinity of the chemical of interest. The user should also
assess whether the possible error is towards false positive
or negative, as given by the CAESAR platform. If the
model under-predicts toxicity for similar compounds, it
should not be used for the specific compound of interest.
The similarity tool described above and this evaluation
of possible prediction errors are two very different con-
cepts, and both checks must be satisfied. In the similar-
ity evaluation the user can see if there are similar
compounds in the training set or not, while in the sec-
ond case the user can assess whether the model gives
good results for them. These six compounds may not be
very similar to the compound of interest, and this may
raise concern about the reliability of the prediction,
even if the predictions for each of the six compounds
are accurate. Alternatively, there may be six very similar
compounds which satisfy the first check on similarity;
but of course if the predictions for these compounds are
wrong, the model is not reliable in this specific case.
For the developmental toxicity model two compounds
of the test set had descriptors out of the range of
descriptors used for the training set. The prediction for
one of them was wrong. Due to the limited number of
compounds, it is impossible to draw conclusions.
Table 4 shows a summary of the similarity in the test
set. A similarity score was calculated as the average value
of three most similar compounds from the training and
test sets for each molecule. Then the mean and standard
deviation of these values were calculated for the four
categories: true positives, true negatives, false positives
and false negatives. Means and standard deviations are
reported for all correctly predicted compounds (true
positive and true negatives) and all incorrectly predicted
(false positive and false negatives). The reliability of the
predictions is related to the similarity scores. The average
similarity for all correctly predicted compounds is signifi-
catively higher than the value for the outliers, and this
was verified by a T test on the two groups (at significance
of 0.95, the T test gave a p-value of 0.0001145). Thus,
compounds for which similar molecules are found in the
training set can be more reliably predicted. Compounds
with less similar molecules in the training set could be
out of the applicability domain of the model and thus
subject to less reliable predictions.
Thus these two tools and the automatic chemometric
check done on the overall set of compounds (with possi-
ble remarks), constitute a battery of three independent
approaches implemented in the CAESAR platform to
address AD and increase the reliability of the model for
use with specific chemicals.
Discussion
According to REACH (Annex XI) [3] a QSAR model is
valid if:
￿ The model is recognized as scientifically valid;
￿ The substance is included in the applicability
domain of the model;
￿ Results are adequate for classification and labeling
and for risk assessment;
￿ The model is adequately documented.
These aspects closely relate to what is also indicated
within the OECD guidelines for validation of the QSAR
models for regulatory purposes [8]. A (Q)SAR model for
regulatory purposes should be associated with the fol-
lowing information:
1) a defined endpoint
2) an unambiguous algorithm
3) a defined domain of applicability
4) appropriate measures of goodness-of-fit, robustness
and predictivity
5) a mechanistic interpretation, if possible.
Table 4 Similarity values of the compounds in the test
set
prediction concordance similarity score
1 number of compounds
True negative (TN) 0.828 +/- 0.075 10
True positive (TP) 0.829 +/- 0.089 39
False positive (FP) 0.717 +/- 0.062 7
False negative (FN) 0.716 +/- 0.087 2
Correctly predicted 0.829 +/- 0.085 49
Incorrectly predicted 0.717 +/- 0.062 9
1. Average of the averages for similarity values of the three most similar
compounds (mean +/- standard deviation).
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is related to the fourth OECD principle, which
addresses the measurements of goodness-of-fit, robust-
ness, and predictivity. The applicability domain require-
ment is explicitly mentioned in the specifications of the
REACH legislation and in the fourth OECD principles.
REACH also requires the model to be suitable for clas-
sification and labeling and for risk assessment. This is
different from the OECD principles. REACH is very
focused on the use of the QSAR model (and any other
tool, not only in silico) for specific legislative purposes.
Whereas the OECD principles are more generic in their
application, and focus on the internal validity of the
model more than on its use within a specific legislation.
The adequate documentation required by REACH is
related to the definition of the endpoint (as in the first
OECD principle), and the algorithm (second OECD
principle). As stated in the CAESAR website [4], the
algorithm is available, which ensures maximum
reproducibility.
REACH gives no recommendations about the
mechanism of action (fifth OECD principle). In the spe-
cific case of developmental toxicity there is lack of
knowledge of the mechanisms of toxicity. Even when
modeling leads to the characterization of particular
molecule fragments related to toxicity, it is not easy to
build a precise mechanistic interpretation for their role
in biological activity (see for example [19]).
The chemical descriptors selected in the CAESAR
models (Tables 5 and 6 for the RF and AFP models,
respectively) may suggest possible mechanisms. In both
models, descriptors take into account topological infor-
mation and electronic properties. In fact, most of the
descriptors are eigenvalues from topological matrices
(BEH, BEL) and spatial autocorrelations from molecular
graphs (GATS, MATS, ATS). In both cases the descrip-
tors are weighted by atom properties like electronegativ-
ity, polarizability and van der Waals volume. Explicit
information about the electro-topological state seems to
be important for modeling, as the remaining descriptors
are E-states (SdssC, ShssNH, SsOH, Gmin) regarding
particular atom groups (NH, OH) and global values
[20]. Thus, it can be argued that the prediction of toxi-
city is related to the presence of certain groups, like sec-
ondary amines, and hydroxyl groups (related to
hydrophilicity), polarizability and electronegativity
(related to reactivity), and steric factors (which may play
a role in reducing reactivity).
In the CAESAR models, we paid great attention to the
quality and scientific validity of the model, assessed as
described above. The overall quality check also involved
checking chemical structures (assessed by at least two
separate laboratories) and toxicity data, which were
examined by expert toxicologists in the CAESAR
consortium.
The RF model, implemented on the web, was devel-
oped with the aim of minimizing false negatives (com-
pounds that are predicted as safe when they are in fact
toxic). False negative predictions have an impact on
human health and the environment, and thus assessors
want to avoid them. The method we propose contri-
butes to the debate on the use of QSAR models for this
particular endpoint, knowing that the number of com-
pounds currently available is not very high, so the avail-
able data set may not fully represent certain chemicals
to be assessed.
REACH does in fact require an assessment of the suit-
ability of each specific QSAR model for the particular
chemical under evaluation. As we explained above, in
order to take this into account we developed special
tools to assess the differences between the chemical we
Table 5 The list of descriptors used in the RF model
Symbol Definition
Icycem Mean information on the vertex cycle matrix equality
BEHm1 Highest eigenvalue n. 1 of Burden matrix/weighted by atomic
masses
BELp3 Lowest eigenvalue n. 3 of Burden matrix/weighted by atomic
polarizabilities
BELv1 Highest eigenvalue n. 1 of Burden matrix/weighted by atomic
van der Waals volumes
BELv8 Highest eigenvalue n. 8 of Burden matrix/weighted by atomic
van der Waals volumes
GATS1p Geary autocorrelation - lag 1/weighted by atomic
polarizabilities
GATS2m Geary autocorrelation - lag 2/weighted by atomic masses
GATS3v Geary autocorrelation - lag 3/weighted by atomic van der
Waals volumes
MATS1p Moran autocorrelation - lag 1/weighted by atomic
polarizabilities
MATS4p Moran autocorrelation - lag 4/weighted by atomic
polarizabilities
MATS4v Moran autocorrelation - lag 4/weighted by atomic van der
Waals volumes
SdssC Sum of all (aC –) E-State values in molecule
ShssNH Sum of all [– NH – ] E-State values in molecule
Table 6 The list of the descriptors used in the AFP model
Symbol Definition
SsOH Sum of all (– OH) E-State values in molecule
Gmin Smallest atom E-State value in molecule
BEHv1 Highest eigenvalue n. 1 of Burden matrix/weighted by atomic
van der Waals volumes
BELe1 Lowest eigenvalue n. 1 of Burden matrix/weighted by atomic
Sanderson electronegativities
BELp2 Lowest eigenvalue n. 1 of Burden matrix/weighted by atomic
Sanderson electronegativities
ATS8m Broto-Moreau autocorrelation of a topological structure - lag
8/weighted by atomic masses
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model. The user can see the similarity score, and see
the performance of the model for the six compounds
most similar to that to be predicted, and therefore has a
direct feed-back and appreciation not only on the mod-
el’s statistical properties (see Table 1), but also whether
it is likely to be reliable for the compound under exami-
nation. There are several characteristics of the different
tools for applicability domain we developed: the tools
for descriptor range and similarity are a priori, based on
the input space. Alternatively, the tool with associated
errors relates to the output space of the model, i.e. to
the toxicity property, since it reports the experimental
and predicted toxicity value, and it is a posteriori tool,
since it assesses the results obtained by the model.
The applicability domain is specifically assessed for the
compound of interest, and the user has a direct evalua-
tion of the reliability of the model for the space around
the target compound. Thus the requirements of REACH
are satisfied.
Conclusions
REACH promotes innovation and requires that animal
models are used only if other methods are not suitable.
The use of valid QSAR methods is foreseen within
REACH. Within CAESAR we developed models for
developmental toxicity. Then a platform was created to
make the model freely available through the web.
All models were statistically evaluated using strict cri-
teria. Performance was superior to that of other models
using the same data set. Since this data set is not very
large and may limit the use of the model, we developed
tools to guide the user toward a safer application. For
example, the user can check the difference between the
experimental and predicted value for compounds similar
to the chemical of interest.
Experimental
Toxicity data
The developmental toxicity data employed in CAESAR
project comprises 292 compounds extracted from
Arena et al. [5] with their names, CAS numbers, mole-
cular structures and toxicity classes. This developmen-
tal toxicity database was constructed by researchers in
the Department of Environmental and Occupational
Health at the University of Pittsburgh for computa-
tional analysis, by combining subsets of information
from the Teratogen Information System (TERIS) [6]
and US Food and Drug Administration (FDA) guide-
lines [7]. Both sources are evaluations of the existing
human and animal data on potentially teratogenic che-
micals, which physicians used for reference. The
TERIS compilation is skewed toward a complete eva-
luation of the animal data whereas the FDA discussion
emphasizes human studies or case reports, with refer-
ence to related animal studies. The original data set
includes 293 compounds, but we had to eliminate
Azatguiorube, because we found no structural informa-
tion about this compound in two databases of chemical
structures: Chemfinder [21], and ChemIDPlus [22].
Two CAESAR partners individually checked all chemi-
cal structures with these databases, in order to be sure
that the chemical structures to be used for modeling
were correct. We also corrected the name of the che-
mical Dotheipin into Dothiepin. Finally, we removed
inorganic ions, which were present for some com-
pounds (such as Cl
- and K
+) and water molecules (pre-
sent in one case). The full list of compounds is given
in Additional file 2.
The developmental toxicity data set was divided into
five categories, according to the FDA criteria, with the
help of CAESAR Partner Liverpool John Moores Univer-
sity, as indicated in Table 7. Then, for developing classi-
fication models, the developmental toxicity data set was
divided in two classes, i.e. non developmental toxicant
(N) and developmental toxicant (D), as indicated in
Table 7. Class N merges the first two FDA categories A
and B, and the class D includes all compounds belong-
ing to categories C, D and X. We notice that the frac-
tion of positive and negative compounds is different
than in the data set use by Arena et al. [5]. As a conse-
quence, the model is more conservative and somehow
biased toward predicting positive scores.
Finally, the data set was split into training and test
sets using rational design, by CAESAR Partner Helm-
holtz-Zentrum für Umweltforschung, using ChemProp
[23,24]. Briefly, all compounds were sorted according to
a hierarchical system of classes in relation to functional
groups. Within classes, the compounds were then sorted
according to halogen substitution, aromaticity, bond
orders, ring contents, and number of atoms. Particular
attention was paid to ordering compounds with mixed
functional property groups. The test set was separated
from the sorted list by keeping the relations between
these compound classes in both sets as close as possible
to the relations in the total set. The test set size was set
to 20% of the overall data set. The selection of optimal
training and test set sizes has been discussed in several
papers [25,26] leading to the conclusion that while it is
important to validate a QSAR model with a good exter-
nal set, if the splitting leads to a training set smaller
than 75-85% of the original data set, the modeling qual-
ity may be affected.
The final training and test sets include respectively
234 and 58 compounds, respectively (Table 8).
All the 292 chemicals, with their experimental FDA
categories and corresponding binary developmental toxi-
city classes, are listed in Additional file 1.
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Chemical descriptors have been calculated with the fol-
lowing programs: DRAGON [16], T.E.S.T. [27] and
MDL [28]. Only bi-dimensional descriptors were taken
into account, since tri-dimensional descriptors require
optimization of the molecular structure. This choice
also enabled the CAESAR web application to accept the
SMILES strings as input (a very compact and easy way
to handle molecule format).
Descriptor selection
Using hundreds of descriptors can lead to false “chance”
correlations between the descriptors and biological
activity. To avoid this problem, a variety of methods
were employed in the CAESAR project to reduce the
data ‘noise’ (a procedure called feature selection). Differ-
ent methods were used for the RF and AFP models, as
below described. In both cases, selection was based on
the descriptors of the compounds of the training set.
To select the chemical descriptors for the RF model
we evaluated the following tools based on the software
WEKA [29] or on the multilevel-self organization. The
goal of multilevel-self-organization is to select the set of
the most important input variables which best satisfy
the final aim of modeling. This approach tightly embeds
feature selection into the modeling process [30,31].
In particular, we used the following WEKA algo-
rithms:
￿ Weka.attributeSelection.GreedyStepwise performs a
greedy forward or backward search through the
space of attribute subsets. It may start with no/all
attributes or from an arbitrary point in the space. It
s t o p sw h e nt h ea d d i t i o n / d e l e t i o no fa na t t r i b u t e
results in a decrease in evaluation statistics.
￿ Weka.attributeSelection.BestFirst searches the
space of attribute subsets by greedy hill-climbing
augmented with a backtracking facility. Setting the
number of consecutive non-improving nodes, it
allows control of the level of backtracking done.
BestFirst can start with the empty set of attributes
and search forward, or can start with the full set of
attributes and search backward.
￿ Weka.attributeSelection.LinearForwardSelection is
an extension of the BestFirst algorithm. It takes a
restricted number of k attributes into account.
Fixed-set selects a fixed number k of attributes,
increasing k in each step when fixed-width is
selected.
￿ Weka.attributeSelection.ClassifierSubsetEval evalu-
ates the attribute subset on training data or a sepa-
rate hold out testing set. It uses a classifier to
estimate the ‘merit’ of a set of attributes.
￿ NoConstant90 is a pre-selection on the attributes.
It deletes attributes with more than 90% of the same
value. NoConstant90 has been used coupled with a
feature selection algorithm (for example BestFirst).
Table 8 Splitting of developmental toxicity compounds,
as in table 7
Classes Total
compounds
Training
Set
Test
Set
Non-developmental
toxicant
91 74 17
Developmental toxicant 201 160 41
Total number of
compounds
292 234 58
Table 7 Division of the developmental toxicity data set according to the FDA Guidelines and CAESAR binary classes
FDA classes Definition CAESAR Binary class Total compounds
Category A Negative human studies
Category B Negative animal studies
No human studies executed Non-developmental toxicant 91
OR
Positive animal studies
Negative human studies
Category C Positive animal studies
No human studies executed
OR
No studies at all
Category D Positive human studies Developmental toxicant 201
Category X Animal OR human studies show abnormalities
AND/OR
Evidence of fetal risk based on human experience
292
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RF model using the multileveled-self organization
reported in Table 5 with a short description. They were
calculated by T.E.S.T. software.
For the AFP model Hybrid Selection Algorithm (HSA)
was used to select the best parameters out of the 790
molecular descriptors for classifying the chemicals by
their toxicity potency. This method combines the
Genetic Algorithms (GA) [32,33] concept with stepwise
regression [34]. GA are inspired by Darwin’st h e o r y
about evolution or population genetics. GA start with a
set of solutions (represented by chromosomes) called the
population. Solutions from one population are taken
a n du s e dt of o r man e wp o p u l a t i o n .T h ea s s u m p t i o ni s
that the new population will be better than the old one.
Solutions are selected to form new solutions (offspring)
according to their fitness - if they are more suitable,
they have more chances of reproducing. GA work on
the principle of repetition until some condition is satis-
fied (for example number of populations or improve-
ment of the best solution).
Usually GA are applicable to problems where little
information is available but they are not particularly sui-
table for local searches. Therefore a stepwise approach
was combined with GA in order to reach local conver-
g e n c e[ 3 4 , 3 5 ] ,a si ti sq u i c ka n dc a nf i n ds o l u t i o n si n
“promising” areas already identified. A specific index
was applied, derived from the fuzzy clustering method,
to evaluate the fitness function. This index has the fol-
lowing advantages. It can be calculated quite quickly
and estimates the descriptor relevance by analyzing
complex molecular distributions. To prevent over-fitting
and poor generalization, a cross-validation procedure
was included in the algorithm during the selection pro-
cedure. Thus, the original training dataset was randomly
split into sub-training and validation sets so the fitness
score of each chromosome was derived from the combi-
nation of the scores of the sub-training and validation
sets.
The following parameters were used in processing the
developmental toxicity data set: fuzzy parameters:
weighting coefficient was set at 1.5, tolerance conver-
gence was 0.001, number of iterations was 30 and clus-
ter number was 6; genetic parameters: chromosome
number was 10, chromosome size = total number of
descriptors used; initial active descriptors in each chro-
mosome = 8, crossover point number = 1, percentage of
rejections = 0.1, percentage of crossover = 0.8, percen-
tage of mutation = 0.05, number of generations = 10;
stepwise parameters: ascending coefficient = 0.02, des-
cending coefficient = -0.02. At the end six molecular
descriptors were chosen for the AFP model; they are
reported in Table 6 with a short description. They were
calculated by DRAGON and MDL software.
Model definition
Several methods have been used to develop binary clas-
sification models. They are all implemented in WEKA:
￿ weka-MultilayerPerceptron+Back_Propagation: a
neural network that uses a backpropagation algo-
rithm to classify instances.
￿ weka-Tree_RandomForest: it constructs a forest of
random trees. For more information, see Breiman
[36].
￿ weka-tree_J48: it generates a pruned or unpruned C
4.5 decision tree. For more information, see Quinlan
[37].
Even though other methods gave similar values, for
the best results the weka-Tree RandomForest was cho-
sen as the algorithm for implementation of the model.
Table 5 shows the list of T.E.S.T. [27] descriptors used
in the RF model. The model was trained setting the fol-
lowing parameters: numbers of trees = 10, maximum
depth of the trees = 12.
We used Adaptive Fuzzy Partition (AFP) [38] to gen-
erate models to predict the developmental toxicity
class according to the binary classification from Table
7. This is a supervised classification method imple-
menting a fuzzy partition algorithm [39] already
reported in database mining issues applied to central
nervous system activity [40] and validated elsewhere
[41-46]. It models the relations between molecular
descriptors and chemical activities by dynamically
dividing the descriptor space into a set of fuzzy parti-
tioned subspaces defined by fuzzy rules. The aim of
the algorithm is to select the descriptor and the cut
position, so one gets the maximal difference between
the two fuzzy rule scores generated by the new sub-
spaces. The score is determined by the weighted aver-
age of the chemical activity values in an active
subspace A and its neighboring subspaces.
Let us assume the working space is an n-dimension
hyperspace defined by n molecular descriptors. Each
dimension i can be partitioned into L intervals Iij, where
j represents an interval in the selected partition. Indi-
cated by P(x1, ..., xn) a molecular vector in an n-dimen-
sional hyperspace, a rule for a subspace Sk, is derived by
combining n intervals Iij,d e f i n e da sf o l l o w s[ 4 7 ] :i fx 1 is
associated with μ1k(x1)a n dx 2 is associated with μ2k(x2)
... and xN is associated with μNk(xN), then the score of
the activity O for P is OkP, where xi represents the value
of the i
th descriptor for the molecule P, μik is a trapezoi-
dal membership function related to the descriptor i for
the subspace k, and OkP is the biochemical activity value
related to the subspace Sk. The “and” of the fuzzy rule is
represented by the Min operator [48], which selects the
minimal value among all the μik components.
Cassano et al. Chemistry Central Journal 2010, 4(Suppl 1):S4
http://www.journal.chemistrycentral.com/content/4/S1/S4
Page 9 of 11All the rules created during the fuzzy procedure are
considered to establish the model between descriptor
hyperspace and biochemical activities. The global score
in the subspace Sk can be represented by the following
equation:
O=
i
N
j=
M
xiP j APj
i
N
j=
M
xiP j
k
(Min
1
ik ).(
(Min
1
ik
µ
µ
() )
() )
(1)
where M is the number of molecular vectors in a
given subspace, N is the total number of descriptors,
µik() xiP j is the fuzzy membership function related to
the descriptor i for the molecular vector Pj,a n dAPj is
the experimental activity of the compound Pj. A classic
centroid defuzzification procedure [49] is implemented
to determine the chemical activity of a new test mole-
cule. All the subspaces k are considered and the general
formula to compute the score of the activity O for a
generic molecule Pj is
O(
(Min
1
N_subsp
ik .(
(Min ik
1
N P=
i
N
k=
xiP j Ok
i
N xiP j
k=
j)
() ) )
() )
µ
µ
_ _subsp (2)
where N_subsp represents the total number of
subspaces.
The AFP model was built on the training set using the
following parameters: maximum number of rules for
each chemical activity = 30; minimum number of com-
pounds for a given rule = 2; maximum number of cuts
for each axis = 4. The trapezoidal parameters used were:
p/wi = 1.2 and q/wi = 0.9.
The AFP method gives the degrees of membership of
the different classes for each compound within a 0 to 1
range. A compound is assigned to a given class if its
degree of membership is superior to 0.5. The percentage
of compounds correctly predicted is computed by com-
paring their experimental and predicted classes. Table 6
lists the descriptors used in the AFP model.
Additional file 1: CAESAR Application system structure. Description
of the CAESAR architecture.
Additional file 2: Compounds list. List of the chemical compounds
used in the models development by IRFMN and BCX.
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